EBR is a U.S. based medical device company that developed the WiSE CRT System ( WiSE ), an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads. That implantable device is part of a cardiac resynchronization therapy ( CRT ), offering endocardial heart tissue stimulation without …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (FY)
$2M
Net Income (TTM)
-$61M
▼ -19.5% YoY
Op. Margin
-2850.15%
ROIC
-43.26%
▼ -4.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$74M
▼ -37.0% YoY
Op. Cash Flow (TTM)
-$66M
▼ -29.0% YoY
Net Debt
$16M
Cash & Equiv.
$86M
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with EBRCZ
EBR Systems (EBRCZ) in four numbers
Questions about EBR Systems
Is EBR Systems (EBRCZ) overvalued?
At $0.08, EBR Systems' price is 43% above the $0.06 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is EBR Systems' fair value?
Intrinsiqq's calculator puts EBR Systems' fair value at $0.06 a share. It grows revenue per share 5% a year for 5 years, applies an exit P/S of 3.4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.04. Every input can be changed on the Intrinsic Value tab.
Is EBR Systems a high-quality business?
EBR Systems scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is net debt at $16M. The Quality tab shows every check against its target.
Does EBR Systems (EBRCZ) pay a dividend?
No. EBR Systems (EBRCZ) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 11 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 3 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in EBRCZ's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EBRCZ
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.